Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031510 | SUMO activating enzyme complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4HKL5
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016925 | protein sumoylation | 7 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018205 | peptidyl-lysine modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0032446 | protein modification by small protein conjugation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2 | 6 |
GO:0016874 | ligase activity | 2 | 6 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3 | 6 |
GO:0019948 | SUMO activating enzyme activity | 3 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 6 |
GO:0140657 | ATP-dependent activity | 1 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.459 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.401 |
DEG_APCC_DBOX_1 | 99 | 107 | PF00400 | 0.399 |
DOC_MAPK_gen_1 | 65 | 74 | PF00069 | 0.342 |
DOC_MAPK_MEF2A_6 | 67 | 76 | PF00069 | 0.392 |
DOC_MAPK_MEF2A_6 | 79 | 87 | PF00069 | 0.432 |
DOC_MAPK_NFAT4_5 | 71 | 79 | PF00069 | 0.382 |
DOC_PP2B_LxvP_1 | 173 | 176 | PF13499 | 0.417 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.475 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.499 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.460 |
LIG_BIR_III_2 | 9 | 13 | PF00653 | 0.650 |
LIG_BRCT_BRCA1_1 | 83 | 87 | PF00533 | 0.560 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.455 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.475 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.451 |
LIG_GBD_Chelix_1 | 35 | 43 | PF00786 | 0.422 |
LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.413 |
LIG_NRBOX | 169 | 175 | PF00104 | 0.418 |
LIG_NRP_CendR_1 | 199 | 201 | PF00754 | 0.453 |
LIG_Pex14_2 | 162 | 166 | PF04695 | 0.470 |
LIG_PTB_Apo_2 | 165 | 172 | PF02174 | 0.417 |
LIG_REV1ctd_RIR_1 | 188 | 198 | PF16727 | 0.449 |
LIG_SH2_CRK | 40 | 44 | PF00017 | 0.458 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.299 |
LIG_SH2_NCK_1 | 95 | 99 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 180 | 184 | PF00017 | 0.435 |
LIG_SH2_STAT3 | 180 | 183 | PF00017 | 0.438 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.515 |
LIG_SH3_3 | 53 | 59 | PF00018 | 0.423 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.451 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.552 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.552 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.460 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.468 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.513 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.449 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.422 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.450 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.447 |
MOD_Plk_1 | 192 | 198 | PF00069 | 0.451 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.461 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.550 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.302 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.374 |
TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.536 |
TRG_Pf-PMV_PEXEL_1 | 194 | 198 | PF00026 | 0.446 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.444 |
TRG_Pf-PMV_PEXEL_1 | 53 | 58 | PF00026 | 0.400 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2G3 | Leptomonas seymouri | 54% | 70% |
A0A3S7X162 | Leishmania donovani | 87% | 70% |
A4HG77 | Leishmania braziliensis | 100% | 70% |
A4I3A8 | Leishmania infantum | 87% | 70% |
E9AZJ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 70% |
Q4Q8N4 | Leishmania major | 85% | 70% |